GAMCO Investors’s Biohaven BHVN Stock Holding History

GAMCO Investors’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-11,000	Closed	-$263K	–	852
2023 Q2	$263K	Hold	11,000	–	–	﹤0.01%	775
2023 Q1	$150K	Hold	11,000	–	–	﹤0.01%	845
2022 Q4	$153K	Buy	+11,000	New	+$155K	﹤0.01%	844

Other funds holding BHVN

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

RP Management New York $139M AUM 37.98% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

GAMCO Investors's BHVN Position: Q3 2023 in Review

GAMCO Investors sold out of Biohaven (BHVN) in Q3 2023, closing a stake of 11,000 shares — an estimated $263K sold.

GAMCO Investors first reported a position in BHVN in Q4 2022 and held it in 3 quarters. The position peaked at $263K in Q2 2023. 187 funds tracked by Wall St. Rank hold BHVN as of Q3 2023.

GAMCO Investors reported no remaining Biohaven position as of Q3 2023 after selling out during the quarter.
GAMCO Investors sold 11,000 Biohaven shares in Q3 2023, an estimated $263K.
GAMCO Investors first reported a position in Biohaven in Q4 2022 and held it in 3 quarters.
GAMCO Investors's Biohaven position peaked at $263K in Q2 2023.
187 funds tracked by Wall St. Rank held Biohaven as of Q3 2023.

Based on GAMCO Investors's 13F filing for Q3 2023, filed 8 Nov 2023.